Rahban SR, Garner WL, et al.
Clinics in plastic surgery. Date of publication 2003 Jan 1;volume 30(1):77-89.
1. Clin Plast Surg. 2003 Jan;30(1):77-89.
Fibroproliferative scars.
Rahban SR(1), Garner WL.
Author information:
(1)University of Southern California Keck School of Medicine, Division of Plastic
and Reconstructive Surgery, LAC+ USC Medical Center, 1450 San Pablo Street, Suite
#2000, Los Angeles, CA 90033, USA.
Fibroproliferative scars remain an ongoing clinical challenge. Both hypertrophic
scars and keloids require multimodal therapy toachieve partally successful
treatment. At the present time incomplete understanding about the pathogenesis of
fibroproliferative scars makes targeted, mechanistic treatment impossible. As
understanding of these abnormal wound problems increases, more effective
treatments will likely be available. Until that time, clinicians must utilize
existing knowledge to treat patients while continuing to experiment with new
approaches.
DOI: 10.1016/s0094-1298(02)00069-x
PMID: 12636218 [Indexed for MEDLINE]
Appears in following Topics:
